New Delhi: Drugs Controller General of India (DCGI) on Monday approved Biological E’s Covid-19 vaccine Corbevax for emergency use among children aged 12-18 years.
The Hyderabad-based pharmaceutical company’s vaccine had earlier received emergency use authorization from DCGI’s Subject Expert Committee for the 12-18 age group, subject to conditions.
Corbevax, to be administered in two doses, is the third vaccine to be approved for 12-18-year olds in India, the others being Bharat Biotech’s Covaxin and Zydus Cadila’s DNA shot ZyCoV-D.
However, Covaxin is mainly being used currently to inoculate children aged 15-18 years.
Corbevax is expected to cost Rs 145 per dose, excluding taxes, ANI reported quoting sources.
National Technical Advisory Group on Immunisation (NTAGI) chief Dr NK Arora said earlier that Corbevax shots were safe, and offered good immunogenicity and higher antibody levels compared to other vector vaccines.
Bhubaneswar: In a significant step towards strengthening higher education, the state Cabinet on Saturday approved…
New York: As talk about the United States of America’s (USA) mounting debts are doing…
Rachi/Bhubaneswar: Odisha Governor Raghubar Das’ daughter-in-law Purnima Das Sahu has won from Jamshedpur East Assembly…
Perth: Openers Yashasvi Jaiswal (batting 90) and KL Rahul (batting 62) put up a stellar…
Boudh: In a major success in anti-naxal operation, security personnel have unearthed two Maoist dumps…
Bhubaneswar: Amid concern over eco-retreat at Pentha beach within Bhitarkanika Wildlife Sanctuary & its ecological…
Balangir: A day after being suspended, Auxiliary Nursing Midwifery (ANM) Mamata Bhoi was arrested by…
Bhubaneswar: The National Highways Authority of India (NHAI) has initiated the process for the construction…